J Neurol Surg B Skull Base 2018; 79(04): 353-360
DOI: 10.1055/s-0037-1608658
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Management and Outcome in Patients with Advanced Juvenile Nasopharyngeal Angiofibroma

Vedantam Rupa
1   Department of ENT, Christian Medical College, Vellore, Tamil Nadu, India
,
Sunithi Elizabeth Mani
2   Department of Radiodiagnosis, Christian Medical College, Vellore, Tamil Nadu, India
,
Selvamani Backianathan
3   Department of Radiation Therapy, Christian Medical College, Vellore, Tamil Nadu, India
,
Vedantam Rajshekhar
4   Department of Neurological Sciences, Christian Medical College, Vellore, Tamil Nadu, India
› Author Affiliations
Further Information

Publication History

16 June 2017

30 September 2017

Publication Date:
27 November 2017 (online)

Abstract

Objective To report the management outcome in a series of patients with advanced juvenile nasopharyngeal angiofibroma (JNA).

Design Retrospective study.

Setting Tertiary care teaching hospital.

Participants Forty-five patients classified as Radkowski stage IIIA or IIIB who presented to us over the past 10 years.

Main Outcome Measures Surgical approaches used and disease free outcomes in patients with advanced JNA.

Results Surgical access for the extracranial component included open (41.9%) and expanded endonasal approaches (58.1%). Craniotomy (16.3%), endoscopy-assisted open approach (7%), or expanded endonasal approach (20.9%) was performed to excise the skull base or intracranial component. Follow up ranged from 4 to 96 months (mean, 20.3 months). Of 35 patients who underwent imaging at the first postoperative follow up, 25 (71.4%) had negative scans. Three symptomatic patients with residual disease underwent endoscopic excision and had negative scans thereafter. Of two others who had radiation therapy, one was disease free and the other lost to follow up. Five others had stable, residual disease. Three patients (8.6%) with recurrent disease underwent surgical excision, of whom two had minimal, stable residual disease. At the last follow-up, 27 (77.1%) patients had negative scans, and 7 (20%) had stable residual disease with one (2.9%) patient lost to follow-up.

Conclusions Advanced JNA may be successfully treated in most cases with expanded endonasal/endoscopy assisted ± craniotomy approach after appropriate preoperative evaluation. At follow-up, only symptomatic patients or those with enlarging residue require treatment; periodic imaging surveillance is adequate for those with stable disease.

 
  • References

  • 1 Glad H, Vainer B, Buchwald C. , et al. Juvenile nasopharyngeal angiofibromas in Denmark 1981-2003: diagnosis, incidence, and treatment. Acta Otolaryngol 2007; 127 (03) 292-299
  • 2 Herman P, Lot G, Chapot R, Salvan D, Huy PT. Long-term follow-up of juvenile nasopharyngeal angiofibromas: analysis of recurrences. Laryngoscope 1999; 109 (01) 140-147
  • 3 Snyderman CH, Pant H, Carrau RL, Gardner P. A new endoscopic staging system for angiofibromas. Arch Otolaryngol Head Neck Surg 2010; 136 (06) 588-594
  • 4 Sessions RB, Wills PI, Alford BR, Harrell JE, Evans RA. Juvenile nasopharyngeal angiofibroma: radiographic aspects. Laryngoscope 1976; 86 (01) 2-18
  • 5 Chandler JR, Goulding R, Moskowitz L, Quencer RM. Nasopharyngeal angiofibromas: staging and management. Ann Otol Rhinol Laryngol 1984; 93 (4 Pt 1): 322-329
  • 6 Radkowski D, McGill T, Healy GB, Ohlms L, Jones DT. Angiofibroma. Changes in staging and treatment. Arch Otolaryngol Head Neck Surg 1996; 122 (02) 122-129
  • 7 Andrews JC, Fisch U, Valavanis A, Aeppli U, Makek MS. The surgical management of extensive nasopharyngeal angiofibromas with the infratemporal fossa approach. Laryngoscope 1989; 99 (04) 429-437
  • 8 Onerci M, Oğretmenoğlu O, Yücel T. Juvenile nasopharyngeal angiofibroma: a revised staging system. Rhinology 2006; 44 (01) 39-45
  • 9 Hosseini SM, Borghei P, Borghei SH, Ashtiani MTK, Shirkhoda A. Angiofibroma: an outcome review of conventional surgical approaches. Eur Arch Otorhinolaryngol 2005; 262 (10) 807-812
  • 10 Howard DJ, Lloyd G, Lund V. Recurrence and its avoidance in juvenile angiofibroma. Laryngoscope 2001; 111 (09) 1509-1511
  • 11 Tyagi I, Syal R, Goyal A. Staging and surgical approaches in large juvenile angiofibroma--study of 95 cases. Int J Pediatr Otorhinolaryngol 2006; 70 (09) 1619-1627
  • 12 Carrau RL, Snyderman CH, Kassam AB, Jungreis CA. Endoscopic and endoscopic-assisted surgery for juvenile angiofibroma. Laryngoscope 2001; 111 (03) 483-487
  • 13 Onerci TM, Yücel OT, Oğretmenoğlu O. Endoscopic surgery in treatment of juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol 2003; 67 (11) 1219-1225
  • 14 Bales C, Kotapka M, Loevner LA. , et al. Craniofacial resection of advanced juvenile nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg 2002; 128 (09) 1071-1078
  • 15 Pryor SG, Moore EJ, Kasperbauer JL. Endoscopic versus traditional approaches for excision of juvenile nasopharyngeal angiofibroma. Laryngoscope 2005; 115 (07) 1201-1207
  • 16 Hackman T, Snyderman CH, Carrau R, Vescan A, Kassam A. Juvenile nasopharyngeal angiofibroma: the expanded endonasal approach. Am J Rhinol Allergy 2009; 23 (01) 95-99
  • 17 Mehan R, Rupa V, Lukka VK, Ahmed M, Moses V, Shyam Kumar NK. Association between vascular supply, stage and tumour size of juvenile nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 2016; 273 (12) 4295-4303
  • 18 Ballah D, Rabinowitz D, Vossough A. , et al. Preoperative angiography and external carotid artery embolization of juvenile nasopharyngeal angiofibromas in a tertiary referral paediatric centre. Clin Radiol 2013; 68 (11) 1097-1106
  • 19 Mann WJ, Jecker P, Amedee RG. Juvenile angiofibromas: changing surgical concept over the last 20 years. Laryngoscope 2004; 114 (02) 291-293
  • 20 Kamel RH. Transnasal endoscopic surgery in juvenile nasopharyngeal angiofibroma. J Laryngol Otol 1996; 110 (10) 962-968
  • 21 Hofmann T, Bernal-Sprekelsen M, Koele W, Reittner P, Klein E, Stammberger H. Endoscopic resection of juvenile angiofibromas--long term results. Rhinology 2005; 43 (04) 282-289
  • 22 Godoy MDCL, Bezerra TFP, Pinna FdeR, Voegels RL. Complications in the endoscopic and endoscopic-assisted treatment of juvenile nasopharyngeal angiofibroma with intracranial extension. Rev Bras Otorrinolaringol (Engl Ed) 2014; 80 (02) 120-125
  • 23 Fagan JJ, Snyderman CH, Carrau RL, Janecka IP. Nasopharyngeal angiofibromas: selecting a surgical approach. Head Neck 1997; 19 (05) 391-399
  • 24 Petruson K, Rodriguez-Catarino M, Petruson B, Finizia C. Juvenile nasopharyngeal angiofibroma: long-term results in preoperative embolized and non-embolized patients. Acta Otolaryngol 2002; 122 (01) 96-100
  • 25 Kuppersmith RB, Teh BS, Donovan DT. , et al. The use of intensity modulated radiotherapy for the treatment of extensive and recurrent juvenile angiofibroma. Int J Pediatr Otorhinolaryngol 2000; 52 (03) 261-268
  • 26 Lee JT, Chen P, Safa A, Juillard G, Calcaterra TC. The role of radiation in the treatment of advanced juvenile angiofibroma. Laryngoscope 2002; 112 (7 Pt 1): 1213-1220
  • 27 Reddy KA, Mendenhall WM, Amdur RJ, Stringer SP, Cassisi NJ. Long-term results of radiation therapy for juvenile nasopharyngeal angiofibroma. Am J Otolaryngol 2001; 22 (03) 172-175
  • 28 Álvarez FL, Suárez V, Suárez C, Llorente JL. Multimodality approach for advanced-stage juvenile nasopharyngeal angiofibromas. Head Neck 2013; 35 (02) 209-213